Announcement on Pledge of Controlling Shareholder's Shares
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
LBX Pharmacy Chain Joint Stock Company has announced the pledge of shares by its controlling shareholder, LBX Pharmaceutical Group. The controlling shareholder holds a significant number of shares, with a large portion pledged as collateral for financing. The company assures that this pledge will not affect its operations or governance.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
LBX Pharmacy Chain Joint Stock Company on 6ix
Earlier from LBX Pharmacy Chain Joint Stock
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Main Operating Data for Q1 2026
- Announcement on Appointment of Senior Management Members
- Announcement on Progress in Providing Guarantees for Wholly-owned Subsidiaries
- Announcement on Return of Raised Funds Temporarily Used to Supplement Current Capital
Later from LBX Pharmacy Chain Joint Stock
- Announcement on Extension of Stock Pledge Repurchase by Controlling Shareholder
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Release of Pledge and Re-pledge of Controlling Shareholder's Shares
Follow LBX Pharmacy Chain Joint Stock into a list and get an email when it puts out news.
Follow LBX Pharmacy Chain Joint Stock